SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BioLase Technology, Inc. (BLTI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Karl Drobnic who wrote (325)4/1/1998 10:39:00 PM
From: J Stone   of 706
 
Karl,

Your comment relates to one of my posts a while back. I used to be a manufacturing consultant with GE. It was fairly common to see production problems in companies that were making the transition from R&D to product seller. So, a key question may be: Does BLTI have experience "production people" in-house to help speed this transition?

Bottlenecks are the key elements that many people miss. Instead, poor management can lead to large investments into un-needed work-in-progress. This ties up capital where it's not doing the company any good. (At one GE plant, when sales slowed, managers had workers occupy themselves by building housings for units to be sold in the future. In 2 months, the plant had invested $8million into finished housings which would take at least 2 years to sell under good market conditions.)

FWIW

Jeff
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext